Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients

E-ISSN： 1365-2796|277|2|155-166

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.277, Iss.2, 2015-02, pp. : 155-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Novel Pharmaceutical Approaches for Treating Patients with Cystic Fibrosis

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-01 ,pp. : 3252-3263

Bentham Science Publishers

Access to resources Recommend Favorite

New Therapies in Cystic Fibrosis

Current Pharmaceutical Design, Vol. 18, Iss. 5, 2012-02 ,pp. : 614-627

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting a Genetic Killer: Novel Disease-Modifying Therapies for Cystic Fibrosis

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 4, 2006-01 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

The Pathophysiology of the Pancreatic Defect in Cystic Fibrosis

ACTA PAEDIATRICA, Vol. 78, Iss. S363, 1989-11 ,pp. : 41-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

The CLCA gene locus as a modulator of the gastrointestinal basic defect in cystic fibrosis

By Ritzka Margit Stanke Frauke Jansen Silke Gruber Achim Pusch Larissa Woelfl Stefan Veeze Henk Halley Dicky Tümmler Burkhard

Human Genetics, Vol. 115, Iss. 6, 2004-11 ,pp. : 483-491

Springer Publishing Company

Access to resources Recommend Favorite